On December 24, Shanghai Government unveiled the "Work Plan for Developing Medical Artificial Intelligence (2025–2027)" to advance the deep integration of artificial intelligence (AI) with clinical medicine and promote the application of vertical large models in diagnostic support for testing and inspection.

Pertussis is a highly contagious acute respiratory disease that can last for several months and often causes epidemics.

Bacterial or viral infection, that is the question. Haifa-Israel based MeMed Diagnostics is developing a point-of-care platform and immune-based test that will one day be able to provide answers. Such a test could help with the overuse and u

Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said recently. Nebula, which was founded last year by Harvard University researchers including Ge

Nebula Genomics has raised $4.3 million in seed financing from venture capital firms and has also partnered with Veritas Genetics, the company said recently. Nebula, which was founded last year by Harvard University researchers including Ge

Illumina said recently that it has received regulatory clearance for its MiSeqDx system from the China National Drug Administration, enabling it to sell the system in China for diagnostic testing. The clearance of the MiSeqDx in China is a

In 2012, genetic testing company 23andMe announced the opening of its Application Programming Interface (API), which wasintended to empower developers to build a wide range of new applications and tools for the 23andMe community.Six years la

Roche said recently that the US Food and Drug Administration has approved its Cobas EGFR Mutation Test v2 as a companion diagnostic test with AstraZenecas cancer drug Iressa (gefitinib) for first-line treatment of patients with non-small ce

Bruker said recently it has signed a definitive agreement to acquire a majority interest in infectious disease molecular diagnostics firm Hain Lifescience.According to Bruker, Nehren, Germany-based Hain will add capabilities in tuberculosis

Bio-Rad Laboratories reported after the close of the market recentlythat its second quarter revenues increased 14 percent year over year, driven by growth in both its Life Science and Clinical Diagnostics businesses. For the three months end

Abbott recently said that its Diagnostics business revenues grew 47 percent year over year in the second quarter, driven by sales in its rapid diagnostics business, which reflect results for Alere acquired in October 2017. On an organic bas

Xiamen Spacegen, a provider of oncology molecular diagnostics products and services in China, said recentlythat it hadreceived CE marking for six testing kits. These kits include a human thyroid carcinoma RET gene fusions detection kit, whic